| Year |
Citation |
Score |
| 2014 |
Li C, Qi L, Bellail AC, Hao C, Liu T. PD-0332991 induces G1 arrest of colorectal carcinoma cells through inhibition of the cyclin-dependent kinase-6 and retinoblastoma protein axis. Oncology Letters. 7: 1673-1678. PMID 24765199 DOI: 10.3892/Ol.2014.1957 |
0.309 |
|
| 2013 |
Wang Q, Wei F, Lv G, Li C, Liu T, Hadjipanayis CG, Zhang G, Hao C, Bellail AC. The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin. Bmc Cancer. 13: 521. PMID 24182354 DOI: 10.1186/1471-2407-13-521 |
0.368 |
|
| 2013 |
Wang Q, Wei F, Li C, Lv G, Wang G, Liu T, Bellail AC, Hao C. Combination of mTOR and EGFR kinase inhibitors blocks mTORC1 and mTORC2 kinase activity and suppresses the progression of colorectal carcinoma. Plos One. 8: e73175. PMID 23991179 DOI: 10.1371/Journal.Pone.0073175 |
0.32 |
|
| 2012 |
Bellail AC, Hao C. The roadmap of TRAIL apoptotic pathway-targeted cancer therapies: What is next? Expert Review of Anticancer Therapy. 12: 547-9. PMID 22594889 DOI: 10.1586/Era.12.33 |
0.301 |
|
| 2012 |
Bellail AC, Olson JJ, Yang X, Chen ZJ, Hao C. A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma. Cancer Discovery. 2: 140-55. PMID 22585859 DOI: 10.1158/2159-8290.Cd-11-0172 |
0.391 |
|
| 2012 |
Li B, Gao S, Wei F, Bellail AC, Hao C, Liu T. Simultaneous targeting of EGFR and mTOR inhibits the growth of colorectal carcinoma cells. Oncology Reports. 28: 15-20. PMID 22552366 DOI: 10.3892/Or.2012.1786 |
0.321 |
|
| 2012 |
Bellail AC, Olson JJ, Yang X, Chen ZJ, Hao C. Abstract LB-72: A20 ubiquitin ligase-mediated RIP1 polyubiquitin chains inhibits TRAIL-induced apoptosis in glioblastoma Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-72 |
0.399 |
|
| 2012 |
Dong B, Lv G, Wang Q, Wei F, Bellail AC, Hao C, Wang G. Corrigendum to " Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells" [Biochem. Biophys. Res. Commun. 418 (2012) 433-438] Biochemical and Biophysical Research Communications. 420: 485. DOI: 10.1016/J.Bbrc.2012.03.044 |
0.314 |
|
| 2011 |
Ding L, Yuan C, Wei F, Wang G, Zhang J, Bellail AC, Zhang Z, Olson JJ, Hao C. Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP. Cancer Investigation. 29: 511-20. PMID 21877938 DOI: 10.3109/07357907.2011.605412 |
0.406 |
|
| 2011 |
Qi L, Bellail AC, Rossi MR, Zhang Z, Pang H, Hunter S, Cohen C, Moreno CS, Olson JJ, Li S, Hao C. Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis. Apoptosis : An International Journal On Programmed Cell Death. 16: 1150-64. PMID 21877214 DOI: 10.1007/S10495-011-0645-6 |
0.409 |
|
| 2011 |
Chen S, Cao W, Yue P, Hao C, Khuri FR, Sun SY. Celecoxib promotes c-FLIP degradation through Akt-independent inhibition of GSK3. Cancer Research. 71: 6270-81. PMID 21868755 DOI: 10.1158/0008-5472.Can-11-0838 |
0.337 |
|
| 2011 |
Lu J, McEachern D, Sun H, Bai L, Peng Y, Qiu S, Miller R, Liao J, Yi H, Liu M, Bellail A, Hao C, Sun SY, Ting AT, Wang S. Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment. Molecular Cancer Therapeutics. 10: 902-14. PMID 21372226 DOI: 10.1158/1535-7163.Mct-10-0864 |
0.37 |
|
| 2010 |
Lu G, Liu Y, Ji B, Wei F, Hao C, Wang G. Synergistic effect of celecoxib on TRAIL-induced apoptosis in hepatocellular carcinoma cells. Cancer Investigation. 28: 629-34. PMID 20394499 DOI: 10.3109/07357900903095631 |
0.372 |
|
| 2010 |
Bellail AC, Tse MC, Song JH, Phuphanich S, Olson JJ, Sun SY, Hao C. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. Journal of Cellular and Molecular Medicine. 14: 1303-17. PMID 19432816 DOI: 10.1111/J.1582-4934.2009.00777.X |
0.391 |
|
| 2010 |
Bellail AC, Qi L, Zhang Z, Olson J, Li S, Hao C. Abstract 4269: Heterogeneity of glioblastoma stem and non-stem cells in the expression of caspase-8 and response to TRAIL-induced apoptosis Cancer Research. 70: 4269-4269. DOI: 10.1158/1538-7445.Am10-4269 |
0.351 |
|
| 2009 |
Bellail AC, Qi L, Mulligan P, Chhabra V, Hao C. TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. Reviews On Recent Clinical Trials. 4: 34-41. PMID 19149761 DOI: 10.2174/157488709787047530 |
0.345 |
|
| 2008 |
Wang P, Zhang J, Bellail A, Jiang W, Hugh J, Kneteman NM, Hao C. Corrigendum to “Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells” [Cell Sig. 19 (11) (2007) 2237] Cellular Signalling. 20: 268. DOI: 10.1016/J.Cellsig.2007.09.001 |
0.358 |
|
| 2007 |
Wang P, Zhang J, Bellail A, Jiang W, Hugh J, Kneteman NM, Hao C. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells. Cellular Signalling. 19: 2237-2246. PMID 17693058 DOI: 10.1016/J.Cellsig.2007.06.001 |
0.407 |
|
| 2007 |
Song JH, Tse MC, Bellail A, Phuphanich S, Khuri F, Kneteman NM, Hao C. Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells. Cancer Research. 67: 6946-55. PMID 17638906 DOI: 10.1158/0008-5472.Can-06-3896 |
0.415 |
|
| 2007 |
Hao C, Tse MCL, Bellail A. Ubiquitination of the DISC defines TRAIL-induced apoptotic and non-apoptotic signals: Implications in cancer therapies The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A31-B |
0.328 |
|
| 2006 |
Li YC, Tzeng CC, Song JH, Tsia FJ, Hsieh LJ, Liao SJ, Tsai CH, Van Meir EG, Hao C, Lin CC. Genomic alterations in human malignant glioma cells associate with the cell resistance to the combination treatment with tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 2716-29. PMID 16675563 DOI: 10.1158/1078-0432.Ccr-05-1980 |
0.386 |
|
| 2006 |
Song JH, Bellail A, Tse MC, Yong VW, Hao C. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 3299-308. PMID 16554480 DOI: 10.1523/Jneurosci.5572-05.2006 |
0.407 |
|
| 2006 |
Wang P, Song JH, Song DK, Zhang J, Hao C. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis. Cellular Signalling. 18: 1528-1535. PMID 16442262 DOI: 10.1016/J.Cellsig.2005.12.004 |
0.386 |
|
| 2006 |
Wang CX, Song JH, Song DK, Yong VW, Shuaib A, Hao C. Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2 Cell Death and Differentiation. 13: 1203-1212. PMID 16273078 DOI: 10.1038/Sj.Cdd.4401804 |
0.363 |
|
| 2005 |
Alladina SJ, Song JH, Davidge ST, Hao C, Easton AS. TRAIL-induced apoptosis in human vascular endothelium is regulated by phosphatidylinositol 3-kinase/Akt through the short form of cellular FLIP and Bcl-2. Journal of Vascular Research. 42: 337-47. PMID 15985761 DOI: 10.1159/000086599 |
0.318 |
|
| 2005 |
Xiao C, Yang BF, Song JH, Schulman H, Li L, Hao C. Inhibition of CaMKII-mediated c-FLIP expression sensitizes malignant melanoma cells to TRAIL-induced apoptosis. Experimental Cell Research. 304: 244-55. PMID 15707589 DOI: 10.1016/J.Yexcr.2004.11.002 |
0.412 |
|
| 2005 |
Song JH, Wang CX, Song DK, Wang P, Shuaib A, Hao C. Interferon γ Induces Neurite Outgrowth by Up-regulation of p35 Neuron-specific Cyclin-dependent Kinase 5 Activator via Activation of ERK1/2 Pathway Journal of Biological Chemistry. 280: 12896-12901. PMID 15695523 DOI: 10.1074/Jbc.M412139200 |
0.324 |
|
| 2004 |
Hao C, Song JH, Hsi B, Lewis J, Song DK, Petruk KC, Tyrrell DLJ, Kneteman NM. TRAIL Inhibits Tumor Growth but Is Nontoxic to Human Hepatocytes in Chimeric Mice Cancer Research. 64: 8502-8506. PMID 15574753 DOI: 10.1158/0008-5472.Can-04-2599 |
0.367 |
|
| 2004 |
Hao C, Song JH, Vilimanovich U, Kneteman NM. Modulation of TRAIL signaling complex. Vitamins and Hormones Series. 67: 81-99. PMID 15110173 DOI: 10.1016/S0083-6729(04)67006-3 |
0.332 |
|
| 2003 |
Song JH, Song DK, Pyrzynska B, Petruk KC, Van Meir EG, Hao C. TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways. Brain Pathology (Zurich, Switzerland). 13: 539-53. PMID 14655759 DOI: 10.1111/J.1750-3639.2003.Tb00484.X |
0.421 |
|
| 2003 |
Yang BF, Xiao C, Roa WH, Krammer PH, Hao C. Calcium/calmodulin-dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells. The Journal of Biological Chemistry. 278: 7043-50. PMID 12496285 DOI: 10.1074/Jbc.M211278200 |
0.386 |
|
| 2002 |
Zhou Y, Larsen PH, Hao C, Yong VW. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival Journal of Biological Chemistry. 277: 49481-49487. PMID 12388552 DOI: 10.1074/Jbc.M206222200 |
0.356 |
|
| 2002 |
Xiao C, Yang BF, Asadi N, Beguinot F, Hao C. Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. The Journal of Biological Chemistry. 277: 25020-5. PMID 11976344 DOI: 10.1074/Jbc.M202946200 |
0.423 |
|
| 2001 |
Catania A, Urban S, Yan E, Hao C, Barron G, Allalunis-Turner J. Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells. Neuro-Oncology. 3: 89-98. PMID 11296485 DOI: 10.1093/Neuonc/3.2.89 |
0.36 |
|
| Show low-probability matches. |
